Health Information Management

Q&A: Are there new pass-through devices for 2014?

APCs Insider, December 6, 2013

Want to receive articles like this one in your inbox? Subscribe to APCs Insider!

Q: We have started our charge description master (CDM) updates for 2014 and wonder if there will be any pass-through devices for next year. In the 2014 OPPS Proposed Rule, CMS noted that HCPCS codes C1830 (powered bone marrow biopsy needle), C1840 (lens, intraocular [telescopic]), and C1886 (catheter, extravascular tissue ablation, any modality [insertable]) will expire at the end of December.

A:The OPPS proposed rule did note that pass-through payment for these codes will expire at the end of December, as they have met the two-year rule. At the time that the proposed rule was published in July, no other codes met the pass-through status requirement. However, CMS approved a new device code for pass through status on October 1, 2013:

  • C1841, retinal prosthesis, includes all internal and external components

Because this is a new pass-through device, the payment will continue through 2014 and into 2015. Be sure that you retain the HCPCS codes for the other devices on you CDM to ensure that the specific cost information is available to CMS for future rate setting. CMS continues to encourage facilities to report HCPCS Level I and II codes regardless of whether the code is separately payable or packaged, as this insures appropriate cost information for rate-setting under the OPPS.

Editor’s note: Andrea Clark, RHIA, CCS, CPCH, chairman, CEO, and founder of Health Revenue Assurance Associates, Inc., in Plantation, Fl., answered this question.

Want to receive articles like this one in your inbox? Subscribe to APCs Insider!

Most Popular